1 active not recruiting, 1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Obstructive Cardiomyopathy, Hypertrophic: new trials by email Literature Review of Obstructive Cardiomyopathy, Hypertrophic trials Research Report on Obstructive Cardiomyopathy, Hypertrophic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ENABLE-HCM - AI-ENabled Echocardiography With Ultrasound Beyond the Echo Lab for Better HCM Imaging and Expanded Access Hypertrophic Cardiomyopathy (HCM), Cardiac Imaging | Terminated | UltraSight | 36 | 2025-07-25 | 2026-03-09 | |
| A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy Sotagliflozin, Placebo - Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy | Phase 3 | Active not recruiting | Lexicon Pharmaceuticals | 500 | 2024-09-24 | 2026-08-26 |
Cardiomyopathy, Hypertrophic (2)
Aortic Stenosis, Subvalvular (2) · Aortic Valve Disease (2) · Aortic Valve Stenosis (2) · Cardiomyopathies (2) · Cardiovascular Diseases (2) · Heart Diseases (2) · Heart Valve Diseases (2)
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (1)
Lexicon Pharmaceuticals (1) · UltraSight (1)
United States (2) · Argentina (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Croatia (1) · Czechia (1) · France (1) · Georgia (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Poland (1) · Portugal (1)